A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders

Journal of Clinical Psychiatry

Volumn 57, Issue 5, 1996, Pages 207-212

  Castaneda, Ricardo ^a   Sussman, Norman ^a   Westreich, Laurence ^a   Levy, Robert ^a   O'Malley, Mary ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMITRIPTYLINE; FLUVOXAMINE; TRAZODONE;

AFFECTIVE NEUROSIS; ANXIETY; ANXIETY NEUROSIS; CENTRAL NERVOUS SYSTEM DEPRESSION; CONFUSION; DRUG ALCOHOL INTERACTION; DRUG INFORMATION; NEUROTRANSMISSION; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REVIEW; SLEEP;

ALCOHOL DRINKING; ANXIETY DISORDERS; CENTRAL NERVOUS SYSTEM; CONFUSION; DEPRESSIVE DISORDER; DRUG INTERACTIONS; ETHANOL; FEMALE; HUMANS; MALE; NEUROTRANSMITTER AGENTS; PSYCHOTROPIC DRUGS; RECEPTORS, NEUROTRANSMITTER; RISK FACTORS; SLEEP; SLEEP DISORDERS; TEMPERANCE; TREATMENT OUTCOME;

EID: 0029942832     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Mino Y, Tsuda T, Aoyama H, et al. Relationship between alcohol use and depressive/anxiety symptoms among a general population: a review of literature. Arukoru Kenkyuto Yakubutsu Ison [Japanese Journal of Alcohol Studies and Drug Dependence] 1992;27(3):242-253
2. Hyman SE, Nestler EJ. The Molecular Foundations of Psychiatry. Washington, DC: American Psychiatric Press; 1993
3. Golding JM, Burnam MA, Wells KB, et al. Alcohol use, depressive symptoms, and cultural characteristics in two Mexican-American samples. Int J Addict 1993;28(5):451-476
4. Haack MR, Harford TC, Parker DA. Alcohol use and depression symptoms among female nursing students. Alcohol Clin Exp Res 1988;12(3): 365-367
5. Chait ID, Perry JL. Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology 1994;115(3):340-349
6. Ogata M, Mendelson JH, Mello NK, et al. Adrenal function and alcoholism. Psychosom Med 1971;33:159-180
7. Castaneda R, Cushman P. Alcohol withdrawal: a review of clinical management. J Clin Psychiatry 1989;50:278-284
8. Castaneda R, Lifshutz H, Westreich L, et al. Concurrent cocaine withdrawal is associated with reduced severity of alcohol withdrawal. Compr Psychiatry 1995;36(6):441-447
9. Miller RJ. Multiple calcium channels and neuronal function. Science 1987;235:46-52
10. Hoffman PL. Central nervous system effects of neurohypophyseal peptides. In: Smith CW, ed. The Peptides. New York, NY: Academic Press; 1987:239-295
11. Meyer HH. Zur Theorie der Alkoholnarkose, III: Der Einfluss wechselnder Temperature auf Wirkungesstarke und Teilunskoeffizient der Narkotica. Nauyn-Schmiedebergs Archives of Experimental Pathology and Pharmacology 1990;46:338-346
12. Goldstein DB, Chin JH. Interaction with biological membrane. Federation Proceedings 1981;40:1073-1076
13. Tabakoff B, Hoffman PL. Biochemical pharmacology of alcohol. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:1521-1526
14. Hoffman PL, Tabakoff B. Ethanol's action on brain biochemistry. In: Tarter RE, van Thiel DH, Edwards KL, eds. Alcohol and the Brain: Chronic Effects. New York, NY: Plenum; 1985:19-68
15. Lovinger DM, White G, Weight FF. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 1989;243:1721-1724
16. Nutt D, Glue P. Monoamines and alcohol. Br J Addict 1986;81:327-338
17. Nestoros JN. Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science 1980;209:708-710
18. Tabakoff B, Hoffman PL. Alcohol interactions with brain opiate receptors. Life Sciences 1983;32:197-204
19. Khatami S, Hoffman PL, Shibuya T, et al. Selective effects of ethanol on opiate receptors subtypes in the brain. Neuropharmacology 1987;26: 1503-1507
20. Davis VE, Walsh MJ. Alcohol, amines and alkaloids: a possible biochemical basis for alcohol addiction. Science 1970;167:1005-1007
21. Suzdak PD, Glowa JN, Schwartz RD, et al. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science 1986;234: 1243-1247
22. Martin D, Swartzwendler HS. Ethanol inhibits release of excitatory amino acids from slices of hippocampal area CAI. Eur J Pharmacol 1992; 219:469-472
23. Tsai G, Gastfriend DR, Coyle JT. The glutamatergic basis of human alcoholism. Am J Psychiatry 1995;152:332-340
24. Schildkraut JJ. The cathecholamine hypothesis of depression: a review of supporting evidence. Am J Psychiatry 1965;122:509-522
25. Costa E. Benzodiazepines and neurotransmitters. Arzneimittelforschung 1980;30:858-861
26. Carroll BJ, Feinberg M, Greden JF, et al. A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry 1981;38:15-22
27. Nishikawa T, Scatton B. Neuroanatomical site of the inhibitory influence of anxiolytic drugs on central serotonergic transmission. Brain Res 1986; 371:123-132
28. Charney DS, Bremmer JD, Redmond E Jr. Noradrenergic neural substrates for anxiety and fear: clinical associations based on preclinical research. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:387-395
29. Grace M. Phasic versus tonic dopamine release and modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991;31:1-24
30. Johnson KM Jr. Neurochemistry and neurophysiology of phencyclidine. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:1581-1588
31. Blanchard RJ, Magee L, Veniegas T, et al. Alcohol and anxiety: ethopharmacology approaches. Prog Neuropsychopharmacol Biol Psychiatry 1993;17(2):171-182
32. Brown SA, Irwin M, Schuckit MA. Changes in anxiety among abstinent male alcoholics. Journal of Studies on Alcohol 1991;52(2):55-61
33. Kranzler HR, Liebowitz NR. Anxiety and depression in substance abuse: clinical implications. Med Clin North Am 1988;72(4):867-885
34. Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 1994;151:1723-1734
35. Borg S, Kvande H, Mossberg D, et al. Central nervous system noradrenaline metabolism and alcohol consumption in man. Pharmacol. Biochem Behav 1983;18:375-378
36. Fujimoto A, Nagao T, Ebara T, et al. Cerebral spinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Biochemical Psychiatry 1983;18:1141-1146
37. 1 adrenoceptor agonist. Neuropharmacology 1985;24: 927-930
38. Parker DA, Parker ES, Harford TC, et al. Alcohol use and depression symptoms among employed men and women. Am J Public Health 1987;77(6):704-707
39. Ballenger JC, Goodwin FK, Major LF, et al. Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 1979;36:224-227
40. Naranjo CA, Sellers EM, Roach CA, et al. Zimelidine-induced variations in alcohol intake by non-depressed heavy drinkers. Clin Pharmacol Ther 1984;35:374-381
41. Murphy JM, Waller MB, Gatto GJ, et al. Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats. Alcohol 1988;5:238-286
42. Major LF, Ballenger JC, Goodwin FK, et al. Cerebrospinal fluid homovanillic acid in male alcoholics: effects of disulfiram. Biol Psychiatry 1977;12:635-642
43. Borg S, Weinholdt T. Bromocriptine in the treatment of the alcohol withdrawal syndrome. Acta Psychiatr Scand 1982;65:101-111
44. Mereu G, Fadda F, Gessa GL. Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res 1984; 292:63-69
45. Schuckit MA. Alcohol and depression: a clinical perspective. Acta Psychiatr Scand Suppl 1994;89(suppl 377):28-32
46. Hasin DS, Click H. Depressive symptoms and DSM-III-R alcohol dependence: general population results. Addiction 1993;88(10):1431-1436
47. Liebenluft E, Fiero PL, Bartko JJ, et al. Depressive symptoms and the self-reported use of alcohol, caffeine, and carbohydrates in normal volunteers and four groups of psychiatric outpatients. Am J Psychiatry 1993;150: 294-301
48. Castaneda R, Galanter M, Franco H. Self-medication among addicts with primary psychiatric disorders. Compr Psychiatry 1989;30(1):80-83
49. Castaneda R, Galanter M, Lifshutz H, et al. Effect of drugs abuse on psychiatric symptoms among schizophrenics. Am J Drug Alcohol Abuse 1991;17(3):313-320
50. Castaneda R, Lifshutz H, Galanter M, et al. An empirical assessment of the self-medication hypothesis. Compr Psychiatry 1994;2:180-184
51. Irwin M, Caldwell C, Smith TL, et al. Major depressive disorder, alcoholism and reduced natural killer cell cytotoxicity: role of severity of depressive symptoms and alcohol consumption. Arch Gen Psychiatry 1990;47: 713-719
52. Moeller FG, Gillin JC, Irwin M, et al. A comparison of sleep EEGs in patients with primary major depression and major depression secondary to alcoholism. J Affect Disord 1993;27(1):39-42
53. Rouhani S, Tran G, Leplaideur F, et al. EEG effects of a single low dose of ethanol on afternoon sleep in the nonalcohol-dependent adult. Alcohol 1989;6(1):87-90
54. Aldrich MS, Shipley JE. Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res 1993;17(1):192-196
55. Aubin HJ, Monfort JC, Benoit O, et al. Alcohol, sleep and biological rhythms. Neurophysiol Clin 1993;23(1):61-70
56. Cooper AJ. The effects of intoxication levels of ethanol on nocturnal penile tumescence. J Sex Marital Ther 1994;20(1):14-23
57. Mitler MM, Dawson A, Henriksen SJ, et al. Bedtime ethanol increases resistance of the upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res 1988;12:801-805
58. Scrima L, Hartman PG, Thomas EE, et al. Sleep disordered breathing in non-obese 50- to 69-year-old male snorers and non-snorers: effects of three alcohol doses. Sleep Res 1992;21:263
59. Dolly FR, Block AJ. Increased ventricular ectopy and sleep apnea follow-ing ethanol ingestion in COPD patients. Chest 1993;83(3):69-72
60. Scrima L, Broudy M, Nay KN, et al. Increased severity of obstructive sleep apnea after bedtime alcohol ingestion: diagnostic potential and proposed mechanism of action. Sleep 1982;5:318-328
61. Bliwise NG. Factors related to sleep quality in healthy elderly women. Psychol Aging 1992;7(1):83-88
62. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987;10(4):541-553
63. Erman MK. Insomnia. Psychiatr Clin North Am 1987;10(4):525-539
64. Dijk DJ, Brunner DP, Aeschbach D, et al. The effects of ethanol on human sleep EEG power spectra differ from those of benzodiazepine receptor agonists, Neuropsychopharmacology 1992;7(3):225-232
65. Lemberg L, Rowe H, Berstrom RF, et al. The effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanol. Clin Pharmacol Ther 1985;37(6):658-664
66. Ehlers T, Ritter M. Effects of the tetracyclic antidepressant pirlindole on sensorimotor performance and subjective condition in comparison to im-ipramine and during interaction of ethanol. Neuropsychobiology 1984;12 (1):48-54
67. Stromberg C, Suokas A, Seppala T. Interaction of alcohol with maprotiline or nomifensine: echocardiographic and psychometric effects. Euro J Clin Psychopharmacol 1988;35(6):593-599
68. Seppala T, Stromberg C, Bergman I. Effects of zimelidine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol: a placebo controlled cross-over study. Eur J Clin Psychopharmacol 1984; 27(2):181-189
69. Berlin I, Cournot A, Zimmer R, et al. Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects. Psychopharmacology 1990;100(1):40-45
70. van Harten J, Stevens LA, Raghoebar M, et al. Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function. Clin Pharmacol Ther 1992;52(4):427-435
71. Anandatheerthavarada HK, Shankar SK, Bhamre S, et al. Induction of brain cytochrome P450 111 E1 by chronic ethanol treatment. Brain Res 1993;601:279-285
72. Lane EA, Guthrie S, Linnoila M. Effects of ethanol on drug and metabolite pharmacokinetics. Clin Pharmacokinet 1985;10(3):228-247
73. Salvadori C, Ward C, Defrance R, et al. The pharmacokinetics of the anti-depressant tianeptine and its main metabolite in healthy-influence on alcohol co-administration. Fundam Clin Pharmacol 1990;4(1):115-125
74. Warrignton SJ, Ankier SI, Turner P. An evaluation of possible interactions between ethanol and trazodone or amitriptyline. Br J Clin Pharmacol 1984;18(4):549-597
75. Moriya F, Ishizu HL. Interactive effects of ethanol on benzodiazepine levels in blood and brain of rat. Arukoru Kenkyuto Yakubutsu Ison [Japanese Journal of Alcohol and Drug Dependence] 1992;27:254-265
76. Linnoila MI. Benzodiazepines and alcohol. J Psychiatr Res 1990;2(suppl 24):121-127
77. Mamelak M, Buck L, Csima A, et al. An investigation of the relations of shift work, sleep, the use of chemical substances, and stress. Dissertation Abstracts International 1992;53:3196 Abstract 6B
78. Bond AJ, Silveira JC, The combination of alprazolam and alcohol on behavioral aggression. Journal of Studies on Alcohol 1993;11(suppl):30-39
79. Hyatt MC, Bird MA. Amitriptyline augments and prolongs ethanol-induced euphoria. J Clin Psychopharmacol 1987;7:277-278
80. Frewer U, Lader M. The effects of nefazodone, imipramine and placebo, alone and combined with alcohol in normal subjects. Int Clin Pyschopharmacol 1993;8:13-20
81. Kerr JS, Fairweather DB, Mahendran R, et al. The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly. Int Clin Psychopharmacol 1992;7: 101-108
82. Sussman N. Buspirone: A Review of the Literature. Princeton, NJ: Excerpta Medica; 1995